L. Baldeschi

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 977 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

Luigi Bartalena, G. E. Krassas, Wilmar M. Wiersinga et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 363 citations · Full text

Medicine, Ophthalmology, Pharmacology +13

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey

Douglas B. McKeag, C Lane, John H. Lazarus et al. · British Journal of Ophthalmology · 2006 · 328 citations · Full text

Medicine, Neurology, Ophthalmology +15

TSH‐R expression and cytokine profile in orbital tissue of active <i>vs.</i> inactive Graves’ ophthalmopathy patients

Iris M.M.J. Wakelkamp, Onno Bakker, L. Baldeschi et al. · Clinical Endocrinology · 2003 · 218 citations

Medicine, Ophthalmology, Surgery +14

Surgical or medical decompression as a first‐line treatment of optic neuropathy in Graves’ ophthalmopathy? A randomized controlled trial

Iris M.M.J. Wakelkamp, L. Baldeschi, Peerooz Saeed et al. · Clinical Endocrinology · 2005 · 216 citations

Medicine, Ophthalmology, Surgery +13